, Singapore
421 views

Raffles Medical Group to get positive contribution from China operations: analyst

Its target price was at $1.60.

An analyst said catalysts for Raffles Medical Group include its China operations and revival of medical tourism.

According to its brokerage report, CGS-CIMB said the medical group will see positive contributions in its operations in China. The group has been offering its services in China since 2010. It offers healthcare treatment in eight cities, including Hong Kong.

CGS-CIMB designated a target price for Raffles Medical Group of $1.60.

READ: Raffles Medical Group earnings per share estimate cut by 8-12% for FY22/24

Another catalyst for Raffles Medical Group’s operations is its COVID-19-related services in Singapore, where it could play a role in supporting the government’s efforts to combat the COVID-19 pandemic.

In Singapore, there is an increase of infections in the past two months due to the sub-variants.

“Although the number of Covid-19 patients hospitalised and within the intensive care unit (ICU) remains below peak levels, they have nonetheless contributed to an overall increase in demand for healthcare services,” said CGS-CIMB.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.